Showing results (221-230 of 2,902) with videos related to
Sort By:
Pageof 291
Cancer Gene Therapy|March 4, 2000
Fusogenic effects of murine retroviruses and cationic enhancers of transductionG Xu, F Solaiman, M A Zink, et al.Cancer Gene Therapy|March 4, 2000
Effects of epidermal growth factor, transferrin, and insulin on lipofection efficiency in human lung carcinoma cellsK Yanagihara, H Cheng, P W ChengCancer Gene Therapy|March 4, 2000
Immunogene therapy against mouse leukemia using B7 moleculesT Takahashi, N Hirano, T Takahashi, et al.Cancer Gene Therapy|July 27, 1999
Interleukin-12 cDNA skin transfection potentiates human papillomavirus E6 DNA vaccine-induced antitumor immune responseJ Tan, N S Yang, J G Turner, et al.Cancer Gene Therapy|April 19, 2000
Enhancing hemopoietic drug resistance: a rationale for reconsidering the clinical use of mitozolomideL J Fairbairn, N Chinnasamy, L S Lashford, et al.Cancer Gene Therapy|April 19, 2000
Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cellsK Tasaki, Y Yoshida, T Maeda, et al.Cancer Gene Therapy|April 19, 2000
Transduction of murine colon carcinoma cells with interleukin-15 gene induces antitumor effects in immunocompetent and immunocompromised hostsK Tasaki, Y Yoshida, M Miyauchi, et al.Cancer Gene Therapy|April 19, 2000
Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapyG Coukos, A Makrigiannakis, S Montas, et al.Cancer Gene Therapy|April 19, 2000
Alteration of drug chemosensitivity caused by the adenovirus-mediated transfer of the wild-type p53 gene in human lung cancer cellsS Osaki, Y Nakanishi, K Takayama, et al.Cancer Gene Therapy|April 19, 2000
Newcastle disease virus infection induces B7-1/B7-2-independent T-cell costimulatory activity in human melanoma cellsC C Termeer, V Schirrmacher, E B Bröcker, et al.Pageof 291